-
公开(公告)号:US20110293564A1
公开(公告)日:2011-12-01
申请号:US13147449
申请日:2010-02-04
IPC分类号: A61K38/21 , A61K31/5377 , A61P25/00 , A61P35/00 , A61P37/00 , A61P19/04 , A61P29/00 , A61P1/00 , A61P17/06 , A61P17/00 , A61P37/06 , A61P5/14 , A61P21/04 , A61P27/02 , A61P7/06 , A61P35/02 , A61P9/10 , A61P9/00 , A61P35/04 , A61P31/14 , A61P1/16 , A61P25/16 , A61K39/395 , C07D413/14
CPC分类号: C07D471/04
摘要: This invention relates to compounds of Formula (I) as Pi3k inhibitors for treating autoimmune diseases, inflammatory disorders, multiple sclerosis and other deseases like cancers.
摘要翻译: 本发明涉及作为用于治疗自身免疫疾病,炎症性疾病,多发性硬化和其它疾病如癌症的Pi3k抑制剂的式(I)化合物。
-
公开(公告)号:US08609666B2
公开(公告)日:2013-12-17
申请号:US13147449
申请日:2010-02-04
申请人: Cyril Montagne , Agnés Bombrun , Gwenaelle Desforges-Bouscary , Anna Quattropani , Pascale Gaillard
发明人: Cyril Montagne , Agnés Bombrun , Gwenaelle Desforges-Bouscary , Anna Quattropani , Pascale Gaillard
IPC分类号: A61K31/519 , C07D471/04
CPC分类号: C07D471/04
摘要: This invention relates to compounds of Formula (I) as Pi3k inhibitors for treating autoimmune diseases, inflammatory disorders, multiple sclerosis and other diseases like cancers.
摘要翻译: 本发明涉及作为用于治疗自身免疫疾病,炎症性疾病,多发性硬化症和其它疾病如癌症的Pi3k抑制剂的式(I)化合物。
-
公开(公告)号:US20110257170A1
公开(公告)日:2011-10-20
申请号:US13122799
申请日:2009-09-30
IPC分类号: A61K31/5377 , A61P35/00 , A61P25/28 , A61P37/06 , A61P29/00 , A61P1/00 , A61P17/06 , A61P27/02 , A61P17/00 , A61P35/02 , A61P9/10 , A61P35/04 , A61P1/16 , A61P25/16 , C07D471/04
CPC分类号: C07D471/04
摘要: This invention relates to compounds of Formula (I) as Pi3k inhibitors for treating autoimmune diseases, inflammatory disorders, multiple sclerosis and other diseases like cancers.
摘要翻译: 本发明涉及作为用于治疗自身免疫疾病,炎症性疾病,多发性硬化症和其它疾病如癌症的Pi3k抑制剂的式(I)化合物。
-
公开(公告)号:US20110312960A1
公开(公告)日:2011-12-22
申请号:US13222072
申请日:2011-08-31
申请人: Pascale Gaillard , Anna Quattropani , Vincent Pomel , Thomas Rueckle , Jasna Klicic , Dennis Church
发明人: Pascale Gaillard , Anna Quattropani , Vincent Pomel , Thomas Rueckle , Jasna Klicic , Dennis Church
IPC分类号: A61K31/498 , C07D413/14 , C07D471/04 , A61K31/5377 , A61P37/00 , A61P29/00 , A61P9/00 , A61P25/28 , A61P31/04 , A61P31/12 , A61P37/08 , A61P11/06 , A61P1/18 , A61P13/12 , A61P7/02 , A61P35/00 , A61P37/06 , A61P15/08 , A61P7/00 , A61P11/00 , A61P17/06 , A61P19/04 , A61P1/00 , A61P25/00 , A61P25/14 , A61P9/10 , A61P9/08 , A61P21/00 , A61P35/04 , C07D241/44
CPC分类号: C07D241/44 , C07D401/12 , C07D403/12 , C07D405/12 , C07D407/12 , C07D409/12 , C07D413/12 , C07D417/12 , C07D471/04
摘要: The present invention is related to pyrazine derivatives of Formula (I) in particular for the treatment and/or prophylaxis of autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, bacterial or viral infections, kidney diseases, platelet aggregation, cancer, transplantation, graft rejection or lung injuries.
-
5.
公开(公告)号:US08614215B2
公开(公告)日:2013-12-24
申请号:US12525095
申请日:2008-02-21
申请人: Pascale Gaillard , Vincent Pomel , Isabelle Jeanclaude-Etter , Jerome Dorbais , Jasna Klicic , Cyril Montagne
发明人: Pascale Gaillard , Vincent Pomel , Isabelle Jeanclaude-Etter , Jerome Dorbais , Jasna Klicic , Cyril Montagne
IPC分类号: A61K31/495
CPC分类号: C07D403/12 , C07D241/44 , C07D401/12 , C07D401/14 , C07D403/14 , C07D405/12 , C07D405/14 , C07D409/12 , C07D409/14 , C07D413/12 , C07D451/02
摘要: The present invention is related to quinoxaline compounds of Formula (I) in particular for the treatment of autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, bacterial or viral infections, kidney diseases, platelet aggregation, cancer, transplantation, graft rejection or lung injuries.
摘要翻译: 本发明涉及式(I)的喹喔啉化合物,特别是用于治疗自身免疫性疾病和/或炎性疾病,心血管疾病,神经变性疾病,细菌或病毒感染,肾脏疾病,血小板聚集,癌症,移植,移植排斥 或肺部受伤。
-
公开(公告)号:US20100137308A1
公开(公告)日:2010-06-03
申请号:US12525095
申请日:2008-02-21
申请人: Pascale Gaillard , Vincent Pomel , Isabelle Jeanclaude-Etter , Jerome Dorbais , Jasna Klicic , Cyril Montagne
发明人: Pascale Gaillard , Vincent Pomel , Isabelle Jeanclaude-Etter , Jerome Dorbais , Jasna Klicic , Cyril Montagne
IPC分类号: A61K31/498 , C07D403/12 , C07D401/12 , C07D413/14 , C07D405/14 , C07D405/12 , A61K31/5377 , A61P31/04 , A61P31/12 , A61P37/08 , A61P1/00 , A61P37/06 , A61P7/02 , A61P29/00 , A61P25/28 , A61P9/00 , A61P35/02
CPC分类号: C07D403/12 , C07D241/44 , C07D401/12 , C07D401/14 , C07D403/14 , C07D405/12 , C07D405/14 , C07D409/12 , C07D409/14 , C07D413/12 , C07D451/02
摘要: The present invention is related to quinoxaline compounds of Formula (I) in particular for the treatment of autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, bacterial or viral infections, kidney diseases, platelet aggregation, cancer, transplantation, graft rejection or lung injuries.
摘要翻译: 本发明涉及式(I)的喹喔啉化合物,特别是用于治疗自身免疫性疾病和/或炎性疾病,心血管疾病,神经变性疾病,细菌或病毒感染,肾脏疾病,血小板聚集,癌症,移植,移植排斥 或肺部受伤。
-
公开(公告)号:US08877757B2
公开(公告)日:2014-11-04
申请号:US13222072
申请日:2011-08-31
申请人: Pascale Gaillard , Anna Quattropani , Vincent Pomel , Thomas Rueckle , Jasna Klicic , Dennis Church
发明人: Pascale Gaillard , Anna Quattropani , Vincent Pomel , Thomas Rueckle , Jasna Klicic , Dennis Church
IPC分类号: A01N43/58 , A01N43/60 , A61K31/50 , A61K31/495 , C07D471/00 , C07D403/12 , C07D405/12 , C07D241/44 , C07D471/04 , C07D407/12 , C07D409/12 , C07D401/12 , C07D417/12 , C07D413/12
CPC分类号: C07D241/44 , C07D401/12 , C07D403/12 , C07D405/12 , C07D407/12 , C07D409/12 , C07D413/12 , C07D417/12 , C07D471/04
摘要: The present invention is related to pyrazine derivatives of Formula (I) in particular for the treatment and/or prophylaxis of autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, bacterial or viral infections, kidney diseases, platelet aggregation, cancer, transplantation, graft rejection or lung injuries.
摘要翻译: 本发明涉及式(I)的吡嗪衍生物,特别是用于治疗和/或预防自身免疫疾病和/或炎性疾病,心血管疾病,神经变性疾病,细菌或病毒感染,肾脏疾病,血小板聚集,癌症, 移植,移植排斥或肺部损伤。
-
公开(公告)号:US20090082356A1
公开(公告)日:2009-03-26
申请号:US12064284
申请日:2006-08-25
申请人: Pascale Gaillard , Anna Quattropani , Vincent Pomel , Thomas Rueckle , Jasna Klicic , Dennis Church
发明人: Pascale Gaillard , Anna Quattropani , Vincent Pomel , Thomas Rueckle , Jasna Klicic , Dennis Church
IPC分类号: A61K31/498 , C07D239/72 , A61P25/28 , A61P29/00 , A61P1/00
CPC分类号: C07D241/44 , C07D401/12 , C07D403/12 , C07D405/12 , C07D407/12 , C07D409/12 , C07D413/12 , C07D417/12 , C07D471/04
摘要: The present invention is related to pyrazine derivatives of Formula (I) in particular for the treatment and/or prophylaxis of autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, bacterial or viral infections, kidney diseases, platelet aggregation, cancer, transplantation, graft rejection or lung injuries.
摘要翻译: 本发明涉及式(I)的吡嗪衍生物,特别是用于治疗和/或预防自身免疫疾病和/或炎性疾病,心血管疾病,神经变性疾病,细菌或病毒感染,肾脏疾病,血小板聚集,癌症, 移植,移植排斥或肺部损伤。
-
公开(公告)号:US08071597B2
公开(公告)日:2011-12-06
申请号:US12064284
申请日:2006-08-25
申请人: Pascale Gaillard , Anna Quattropani , Vincent Pomel , Thomas Rueckle , Jasna Klicic , Dennis Church
发明人: Pascale Gaillard , Anna Quattropani , Vincent Pomel , Thomas Rueckle , Jasna Klicic , Dennis Church
IPC分类号: A61K31/50 , A61K31/495 , A01N43/58 , A01N43/60 , C07D241/36
CPC分类号: C07D241/44 , C07D401/12 , C07D403/12 , C07D405/12 , C07D407/12 , C07D409/12 , C07D413/12 , C07D417/12 , C07D471/04
摘要: The present invention is related to pyrazine derivatives of Formula (I) in particular for the treatment and/or prophylaxis of autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, bacterial or viral infections, kidney diseases, platelet aggregation, cancer, transplantation, graft rejection or lung injuries.
摘要翻译: 本发明涉及式(I)的吡嗪衍生物,特别是用于治疗和/或预防自身免疫疾病和/或炎性疾病,心血管疾病,神经变性疾病,细菌或病毒感染,肾脏疾病,血小板聚集,癌症, 移植,移植排斥或肺部损伤。
-
公开(公告)号:US07776854B2
公开(公告)日:2010-08-17
申请号:US10496785
申请日:2002-12-06
IPC分类号: A61K31/535
CPC分类号: A61K31/4184 , A61K31/423 , A61K31/428 , A61K31/506
摘要: The present invention is related to the use of benzazole derivatives of formula (I) for the treatment and/or prevention of scleroderma and its therapeutic implications selected in the group consisting of systemic sclerosis, scleroderma-like disorders, sine scleroderma, liver cirrhosis, interstitial pulmonary fibrosis, Dupuytren's contracture, keloid and other scarring/wound healing abnormalities, postoperative adhesions and reactive fibrosis, as well as chronic heart failure, in particular after myocardial infarction.
摘要翻译: 本发明涉及式(I)的苯并唑衍生物在治疗和/或预防硬皮病中的应用及其治疗意义,其选自系统性硬化症,硬皮病样疾病,正辛硬脂酸,肝硬化,间质性 肺纤维化,Dupuytren挛缩,瘢痕疙瘩和其他瘢痕/伤口愈合异常,术后粘连和反应性纤维化,以及慢性心力衰竭,特别是心肌梗死后。
-
-
-
-
-
-
-
-
-